Ambea AB (publ) (STO:AMBEA)
171.10
-2.60 (-1.50%)
Sep 2, 2026, 5:29 PM CET
Ambea AB Revenue
Ambea AB had revenue of 4.42B SEK in the quarter ending June 30, 2026, with 6.97% growth. This brings the company's revenue in the last twelve months to 17.07B, up 13.19% year-over-year. In the year 2025, Ambea AB had annual revenue of 16.21B with 12.91% growth.
Revenue (ttm)
17.07B
Revenue Growth
+13.19%
P/S Ratio
0.81
Revenue / Employee
414.37K
Employees
41,000
Market Cap
13.74B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 16.21B | 1.85B | 12.91% |
| Dec 31, 2024 | 14.36B | 776.00M | 5.71% |
| Dec 31, 2023 | 13.58B | 625.00M | 4.82% |
| Dec 31, 2022 | 12.96B | 1.28B | 10.99% |
| Dec 31, 2021 | 11.67B | 468.00M | 4.18% |
| Dec 31, 2020 | 11.21B | 66.00M | 0.59% |
| Dec 31, 2019 | 11.14B | 4.99B | 81.24% |
| Dec 31, 2018 | 6.15B | 247.00M | 4.19% |
| Dec 31, 2017 | 5.90B | 490.00M | 9.06% |
| Dec 31, 2016 | 5.41B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 34.24B |
| Swedish Orphan Biovitrum AB | 30.62B |
| Medicover AB | 27.33B |
| Attendo AB | 18.97B |
| AddLife AB | 10.53B |
| Nolato AB | 9.43B |
| Vimian Group AB | 4.99B |
| Sectra AB | 3.65B |
Ambea AB News
- 14 days ago - Ambea AB Earnings Call Transcript: Q2 2026 - Transcripts
- 14 days ago - Ambea AB Quarterly report: Q2 2026 - Filings
- 14 days ago - Ambea AB Slides: Q2 2026 - Filings
- 15 days ago - Earnings To Watch: Ambea AB (OSTO:AMBEA) Q2 2026 -- GF Value Sees 11% Downside - GuruFocus
- 2 months ago - Ambea AB Transcript: M&A announcement - Transcripts
- 2 months ago - Ambea AB Press release: M&A announcement - Filings
- 2 months ago - Ambea AB Slides: M&A announcement - Filings
- 3 months ago - Ambea AB Earnings Call Transcript: Q1 2026 - Transcripts